This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chong, S.
Right arrow Articles by Chernesky, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chong, S.
Right arrow Articles by Chernesky, M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2003, p. 778-782, Vol. 41, No. 2
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.2.778-782.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Specimen Processing and Concentration of Chlamydia trachomatis Added Can Influence False-Negative Rates in the LCx Assay but Not in the APTIMA Combo 2 Assay When Testing for Inhibitors

S. Chong,1*ast; D. Jang,1 X. Song,1 J. Mahony,1 A. Petrich,1 P. Barriga,2 and M. Chernesky1

McMaster University and Father Sean O'Sullivan Research Centre, St. Joseph's Healthcare, Hamilton, Ontario,1 Sainte-Justine Hospital, Montreal, Quebec, Canada2

Received 9 April 2002/ Returned for modification 31 July 2002/ Accepted 12 November 2002

Inhibitors in clinical specimens can be detected by adding the target of nucleic acid amplification to the sample. Introduction of a Chlamydia trachomatis L2 434 preparation containing 12 elementary bodies (EBs) into first-void urine (FVU) from 225 nonpregnant women and 190 pregnant women before specimen processing by the assays produced false-negative rates of 0.48% (2 of 415 specimens) and 13% (44 of 338 specimens) by the APTIMA Combo 2 and the Chlamydia LCx tests, respectively. Reducing the amount of C. trachomatis added to one EB, a concentration closer to the APTIMA Combo 2 test cutoff, for a subset of 244 FVU specimens increased the number of specimens with false-negative results by the APTIMA Combo 2 assay to 7 (2.9%), suggesting that the strength of the input C. trachomatis per specimen has an influence on the number of specimens with false-negative results. Repeat testing after overnight storage and dilution decreased the APTIMA Combo 2 test false-negative rates to 0% (0 of 415 specimens) with the stronger inoculum and 0.8% (2 of 244 specimens) with the weaker inoculum; the false-negative rate of the LCx assay was reduced to 5.4% (18 of 334 specimens). When an additional 70 FVU specimens from women to which 12 EBs were added before specimen processing were tested by the LCx assay, 34 specimens had false-negative results, whereas 21 specimens had false-negative results when the C. trachomatis EBs were introduced after processing. Nine of the 21 specimens to which EBs were added after processing and all of the 34 urine specimens to which the target was added before processing remained falsely negative on repeat testing at a 1:2 dilution, suggesting that input C. trachomatis DNA was lost during processing by the LCx assay. In contrast, the APTIMA Combo 2 assay appears to have a higher sensitivity and either lost little nucleic acid during processing or demonstrated few problems with inhibitors of transcription-mediated amplification.

* Corresponding author. Mailing address: Regional Virology and Chlamydiology Laboratory, St. Joseph's Healthcare, 50 Charlton Ave. East, Hamilton, Ontario L8N 4A6, Canada. Phone: (905) 521-6021. Fax: (905) 521-6083. E-mail: chernesk{at}mcmaster.ca.

Journal of Clinical Microbiology, February 2003, p. 778-782, Vol. 41, No. 2
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.2.778-782.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Mckechnie, M. L., Hillman, R., Couldwell, D., Kong, F., Freedman, E., Wang, H., Gilbert, G. L. (2009). Simultaneous Identification of 14 Genital Microorganisms in Urine by Use of a Multiplex PCR-Based Reverse Line Blot Assay. J. Clin. Microbiol. 47: 1871-1877 [Abstract] [Full Text]  
  • Chen, G., Kobayashi, L., Nazarenko, I. (2007). Effect of Sample Aliquot Size on the Limit of Detection and Reproducibility of Clinical Assays. Clin. Chem. 53: 1962-1965 [Abstract] [Full Text]  
  • Marshall, R., Chernesky, M., Jang, D., Hook, E. W., Cartwright, C. P., Howell-Adams, B., Ho, S., Welk, J., Lai-Zhang, J., Brashear, J., Diedrich, B., Otis, K., Webb, E., Robinson, J., Yu, H. (2007). Characteristics of the m2000 Automated Sample Preparation and Multiplex Real-Time PCR System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J. Clin. Microbiol. 45: 747-751 [Abstract] [Full Text]  
  • Lowe, P., O'Loughlin, P., Evans, K., White, M., Bartley, P. B., Vohra, R. (2006). Comparison of the Gen-Probe APTIMA Combo 2 Assay to the AMPLICOR CT/NG Assay for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Samples from Australian Men and Women.. J. Clin. Microbiol. 44: 2619-2621 [Abstract] [Full Text]  
  • Chernesky, M., Castriciano, S., Jang, D., Smieja, M. (2006). Use of Flocked Swabs and a Universal Transport Medium To Enhance Molecular Detection of Chlamydia trachomatis and Neisseria gonorrhoeae.. J. Clin. Microbiol. 44: 1084-1086 [Abstract] [Full Text]  
  • Chernesky, M., Jang, D., Luinstra, K., Chong, S., Smieja, M., Cai, W., Hayhoe, B., Portillo, E., MacRitchie, C., Main, C., Ewert, R. (2006). High Analytical Sensitivity and Low Rates of Inhibition May Contribute to Detection of Chlamydia trachomatis in Significantly More Women by the APTIMA Combo 2 Assay. J. Clin. Microbiol. 44: 400-405 [Abstract] [Full Text]  
  • Ikeda-Dantsuji, Y., Konomi, I., Nagayama, A. (2005). In vitro assessment of the APTIMA Combo 2 assay for the detection of Chlamydia trachomatis using highly purified elementary bodies. J Med Microbiol 54: 357-360 [Abstract] [Full Text]  
  • Chalker, V. J., Vaughan, H., Patel, P., Rossouw, A., Seyedzadeh, H., Gerrard, K., James, V. L. A. (2005). External Quality Assessment for Detection of Chlamydia trachomatis. J. Clin. Microbiol. 43: 1341-1347 [Abstract] [Full Text]  
  • Chernesky, M. A., Martin, D. H., Hook, E. W., Willis, D., Jordan, J., Wang, S., Lane, J. R., Fuller, D., Schachter, J. (2005). Ability of New APTIMA CT and APTIMA GC Assays To Detect Chlamydia trachomatis and Neisseria gonorrhoeae in Male Urine and Urethral Swabs. J. Clin. Microbiol. 43: 127-131 [Abstract] [Full Text]  
  • Gaydos, C. A., Theodore, M., Dalesio, N., Wood, B. J., Quinn, T. C. (2004). Comparison of Three Nucleic Acid Amplification Tests for Detection of Chlamydia trachomatis in Urine Specimens. J. Clin. Microbiol. 42: 3041-3045 [Abstract] [Full Text]  
  • Boyadzhyan, B., Yashina, T., Yatabe, J. H., Patnaik, M., Hill, C. S. (2004). Comparison of the APTIMA CT and GC Assays with the APTIMA Combo 2 Assay, the Abbott LCx Assay, and Direct Fluorescent-Antibody and Culture Assays for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J. Clin. Microbiol. 42: 3089-3093 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»